NewslettersHepatic Cell NewsFASN Inhibition Targets Multiple Drivers of Nash by Reducing Steatosis, Inflammation and Fibrosis in Preclinical ModelsBy lbeveridge - September 23, 20220137Researchers tested pharmacological inhibition of fatty acid synthase (FASN) in human cell culture and in three diet induced mouse models of NASH.[Scientific Reports]Full Article